Skip to main
PBH

PBH Stock Forecast & Price Target

PBH Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Prestige Consumer Healthcare is experiencing a robust upward trend in its financial outlook, evidenced by an increased EBITDA estimate for 2026 and 2027 by approximately $15 million due to anticipated sales growth. The company is expected to see significant organic volume growth, particularly in Specialty Foods, driven by an acceleration in new product launches and a positive same-store sales performance, notably with a notable increase in September and continuing into October. Furthermore, Prestige's focus on operational efficiencies and reduced input costs could lead to greater-than-expected EBITDA margin expansion, positioning the company for enhanced free cash flow growth and stronger consumer spending in the U.S. market.

Bears say

Prestige Consumer Healthcare faces a negative outlook primarily due to anticipated lower-than-expected revenue growth, combined with EBITDA margin compression driven by persistent increases in input costs. The company is also experiencing challenges in its key markets, which could lead to weaker operating performance from its largest customers. Additionally, potential risks include a lack of acquisition opportunities and the possibility of divesting non-core assets, which could affect its financial leverage and free cash flow.

PBH has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Prestige Brands Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Prestige Brands Holdings (PBH) Forecast

Analysts have given PBH a Buy based on their latest research and market trends.

According to 3 analysts, PBH has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Prestige Brands Holdings (PBH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.